Pharmaceutical Research & Mfrs Washington, DC - 20004

Pharmaceutical Research & Mfrs is categorized under Associations in Washington, DC and active since 1958.

Pharmaceutical Research & Mfrs was established in 1958, and today employs 1 to 4, earning Unknown per year. This is a Associations business, which does work in the B2B market, and is classified as a Associations, under code number 8139100 by the NAICS.

If you are seeking more information, feel free to contact John Castellani, Chief Executive Officer at the company’s single location by writing to 950 F St Nw # 300, Washington, District of Columbia DC 20004 or by phoning (202) 835-3400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pharmaceutical Research & Mfrs
Contact Person: John Castellani, Chief Executive Officer
Address: 950 F St Nw # 300, Washington, District of Columbia 20004
Phone Number: (202) 835-3400
Website Address: phrma.org
Annual Revenue (USD): Unknown
Founded: 1958
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Associations
SIC Code: 8611
NAICS Code: 8139100
Share This Business:

Pharmaceutical Research & Mfrs was started in 1958 to provide professional Associations under the SIC code 8611 and NAICS code 8139100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact John Castellani, Chief Executive Officer for inquiries that concern Pharmaceutical Research & Mfrs by calling the company number (202) 835-3400, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Research & Mfrs can be found at the coordinates 38.89727,-77.02525 as well as the street address 950 F St Nw # 300 in Washington, District of Columbia 20004.

For its online presence, you may visit Pharmaceutical Research & Mfrs’s website at phrma.org and engage with its social media outlets through on Twitter and on Facebook.